Hepatitis C in pregnancy: screening, treatment, and management

American Journal of Obstetrics and Gynecology

Volumn 217, Issue 5, 2017, Pages B2-B12

  Hughes, Brenna L ^a   Page, Charlotte M ^a   Kuller, Jeffrey A ^a  

^a Society for Maternal Fetal Medicine   (United States)

Author keywords

antiviral therapy; HCV; Hepatitis C virus; vertical transmission

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; BREAST FEEDING; CHRONIC HEPATITIS C; FEMALE; FETUS MONITORING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABOR MANAGEMENT; NEWBORN SCREENING; OBSTETRIC DELIVERY; OBSTETRIC PROCEDURE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; AMNIOCENTESIS; CESAREAN SECTION; DISEASE MANAGEMENT; MASS SCREENING; MEDICAL SOCIETY; OBSTETRICS; PERINATOLOGY; PREGNANCY COMPLICATION; PRENATAL CARE; PUERPERIUM; SEXUALLY TRANSMITTED DISEASE; TRANSMISSION;

AMNIOCENTESIS; ANTIVIRAL AGENTS; BREAST FEEDING; CESAREAN SECTION; DELIVERY, OBSTETRIC; DISEASE MANAGEMENT; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; OBSTETRICS; PERINATOLOGY; POSTPARTUM PERIOD; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; SEXUALLY TRANSMITTED DISEASES; SOCIETIES, MEDICAL;

EID: 85029587512     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2017.07.039     Document Type: Article

References (61)

1. Spera, A.M., Eldin, T.K., Tosone, G., Orlando, R., Antiviral therapy for hepatitis C: has anything changed for pregnant/lactating women?. World J Hepatol 8 (2016), 557–565.
2. Prasad, M.R., Honegger, J.R., Hepatitis C virus in pregnancy. Am J Perinatol 30 (2013), 149–159.
3. Joint Panel from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. Recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.org/. Accessed July 12, 2017.
4. American College of Obstetricians and Gynecologists. Viral hepatitis in pregnancy. Practice bulletin no. 86. Obstet Gynecol 110 (2007), 941–955.
5. World Health Organization. Guidelines for the screening, care, and treatment of persons with chronic hepatitis C infection. Available at: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en. Accessed July 12, 2017.
6. van der Meer, A.J., Veldt, B.J., Feld, J.J., et al. Association between sustained virological and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 308 (2012), 2584–2593.
7. Sangiovanni, A., Prati, G.M., Fasani, P., et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43 (2006), 1303–1310.
8. Gallo, C., Capuano, G., Daniele, B., Gaeta, G., Perrone, F., Pignata, S., A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28 (1998), 751–755.
9. Conte, D., Fraquelli, M., Prati, D., Colucci, A., Minola, E., Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31 (2000), 751–755.
10. Gervais, A., Bacq, Y., Bernuau, J., et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 32 (2000), 293–299.
11. Money, D., Boucoiran, I., Wagner, E., et al. Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants. J Obstet Gynaecol Can 36 (2014), 785–794.
12. Paternoster, D.M., Santarossa, C., Grella, P., et al. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 96 (2001), 2751–2754.
13. Resti, M., Azzari, C., Mannelli, F., et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ 317 (1998), 437–441.
14. Fontaine, H., Nalpas, B., Carnot, F., Bréchot, C., Pol, S., Effect of pregnancy on chronic hepatitis C: a case-control study. Lancet 356 (2000), 1328–1329.
15. Pergam, S.A., Wang, C.C., Gardella, C.M., Sandison, T.G., Phipps, W.T., Hawes, S.E., Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 199 (2008), 38.e1–38.e9.
16. Connell, L.E., Salihu, H.M., Salemi, J.L., August, E.M., Weldeselasse, H., Mbah, A.K., Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int 31 (2011), 1163–1170.
17. Huang, Q., Hang, L., Zhong, M., Gao, Y., Luo, M., Yu, Y., Maternal HCV infection is associated with intrauterine fetal growth disturbance. Medicine (Baltimore) 95 (2016), 1–7.
18. Reddick, K.L.B., Jhaveri, R., Gandhi, M., James, A.H., Swamy, G.K., Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 18 (2011), e394–e398.
19. Salemi, J.L., Whiteman, V.E., August, E.M., Chandler, K., Mbah, A.K., Salihu, H.M., Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes. J Viral Hepat 21 (2014), e144–e153.
20. Wijarnpreecha, K., Thongprayoon, C., Sanguankeo, A., Upala, S., Ungprasert, P., Cheungpasitporn, W., Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 41 (2017), 39–45.
21. Reddy U, Thom EA, Prasad M. An observational study of hepatitis C virus in pregnancy (NCT01959321). Available at: https://www.clinicaltrials.gov/ct2/show/NCT01959321?term=hepatitis+c+and+pregnancy&rank=5. Accessed July 12, 2017.
22. Jhaveri, R., Swamy, G.K., Hepatitis C virus in pregnancy and early childhood: current understanding and knowledge deficits. J Pediatr Infect Dis Soc 3 (2014), S13–S18.
23. Mok, J., Pembrey, L., Tovo, P.A., Newell, M.L., When does mother to child transmission of hepatitis C virus occur?. Arch Dis Child Fetal Neonatal Ed 90 (2005), F156–F160.
24. Benova, L., Mohamoud, Y.A., Calvert, C., Abu-Raddad, L.J., Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 59 (2014), 765–773.
25. Checa Cabot, C.A., Stoszek, S.K., Quarleri, J., et al. Mother-to-child transmission of hepatitis C virus (HCV) among HIV/HCV-coinfected women. J Pediatr Infect Dis Soc 2 (2013), 126–135.
26. Snijdewind, I.J.M., Smit, C., Schutten, M., et al. Low mother-to-child-transmission rate of hepatitis C virus in cART treated HIV-1 infected mothers. J Clin Virol 68 (2015), 11–15.
27. European Pediatric Hepatitis C Virus Network. A significant sex–but not elective cesarean section–effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 192 (2005), 1872–1879.
28. Mast, E.E., Hwang, L.Y., Seto, D.S., et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 192 (2005), 1880–1889.
29. Ceci, O., Margiotta, M., Marello, F., et al. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr 33 (2001), 570–575.
30. Ohto, H., Terazawa, S., Sasaki, N., et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 330 (1994), 744–750.
31. Workowski, K.A., Bolan, G.A., Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 63 (2015), 1–137.
32. Aebi-popp, K., Duppenthaler, A., Rauch, A., De Gottardi, A., Kahlert, C., Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. J Virus Erad 2 (2016), 52–54.
33. Orkin, C., Jeffery-Smith, A., Foster, G.R., Tong, C.Y.W., Retrospective hepatitis C seroprevalence screening in the antenatal setting–should we be screening antenatal women?. BMJ Open, 6, 2016, e010661.
34. Prasad, M.R., Hepatitis C virus screening in pregnancy: is it time to change our practice?. Obstet Gynecol 128 (2016), 229–230.
35. Maheshwari, A., Thuluvath, P.J., Management of acute hepatitis C. Clin Liver Dis 14 (2010), 169–176.
36. Centers for Disease Control and Prevention. Testing for HCV infection: an update of guidance for clinicians and laboratories. MMWR Morb Mortal Wkly Rep 62 (2013), 362–365.
37. Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom, J., Tita, A.T.N., Silverman, N.S., No. 38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol 214 (2016), 6–14.
38. Kim, D.K., Riley, L.E., Harriman, K.H., Hunter, P., Bridges, C.B., Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older–United States, 2017. MMWR Morb Mortal Wkly Rep 66 (2017), 136–138.
39. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2015. J Hepatol 63 (2015), 199–236.
40. Pessione, F., Degos, F., Marcellin, P., et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 27 (1998), 1717–1722.
41. Lewis, J.H., Stine, J.G., Review article: prescribing medications in patients with cirrhosis–a practical guide. Aliment Pharmacol Ther 37 (2013), 1132–1156.
42. Jimenez-Peres, M., Gonzalez-Grande, R., Espana Contreras, P., Pinazo Martinez, I., de la Cruz Lombardo, J., Olmedo Martin, R., Treatment of chronic hepatitis C with direct-acting antivirals: the role of resistance. World J Gastroenterol 22 (2016), 6573–6581.
43. US National Library of Medicine. Drug label information: Ribasphere–ribavirin tablet. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf7cf753-b35a-4f04-8dbe-f2cf8e229eec. Accessed July 12, 2016.
44. US Food and Drug Administration. Pregnancy and lactation labeling (drugs) final rule. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm. Accessed July 12, 2017.
45. US National Library of Medicine. Drug label information: Sovaldi–sofosbuvir tablet, film coated. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80beab2c-396e-4a37-a4dc-40fdb62859cf. Accessed July 12, 2017.
46. US National Library of Medicine. Drug label information: Technivie–ombitasvir and paritaprevir and ritonavir. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85130606-e6a4-cf08-4bac-a460a30b0984. Accessed July 12, 2017.
47. US National Library of Medicine. Drug label information: Daklinza–daclatasvir tablet. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9803a6ff-8a3e-4c64-b3d0-7825c7123bf2. Accessed July 12, 2017.
48. US National Library of Medicine. Drug label information: Harvoni–ledipasvir and sofosbuvir tablet, film coated. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4ec77e4-bae8-4db0-b3d5-bde09c5fa075. Accessed July 12, 2017.
49. US National Library of Medicine. Drug label information: Epclusa–velpatasvir and sofosbuvir tablet, film coated. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f30631a-ee3b-4cfe-866b-964df3f0a44f. Accessed July 12, 2017.
50. US National Library of Medicine. Drug label information: Viekira XR–dasabuvir and ombitasvir and paritaprevir and ritonavir. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e9dc175-80cb-b598-d035-4c3d5134c096. Accessed July 12, 2017.
51. US National Library of Medicine. Drug label information: Zepatier–elbasvir and grazoprevir tablet, film coated. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=164dc02a-9180-426a-b8b5-04ab39d2bbd4. Accessed July 12, 2017.
52. US National Library of Medicine. Drug label information: Olysio–simeprevir capsule. US National Library of Medicine DailyMed. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1816fd68-0ed7-4a37-84bb-e298c5ab6e28. Accessed July 12, 2017.
53. Chappell C. Study of hepatitis C treatment during pregnancy (NCT02683005). Available at: https://www.clinicaltrials.gov/ct2/show/NCT02683005?term=hepatitis+c+and+pregnancy&rank=2. Accessed July 12, 2017.
54. Gagnon, A., Davies, G., Wilson, R.D., et al. Prenatal invasive procedures in women with hepatitis B, hepatitis C, and/or human immunodeficiency virus infections. J Obstet Gynaecol Can 36 (2014), 648–653.
55. Cottrell, E.B., Chou, R., Wasson, N., Rahman, B., Guise, J.-M., Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the US Preventive Services Task Force. Ann Intern Med 158 (2013), 109–113.
56. Ghamar Chehreh, M.E., Tabatabaei, S.V., Khazanehdari, S., Alavian, S.M., Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV– mothers: a meta-analysis. Arch Gynecol Obstet 283 (2011), 255–260.
57. McIntyre, P.G., Tosh, K., McGuire, W., Cesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database Syst Rev, 4, 2006, CD005546.
58. Spencer, J.D., Latt, N., Beeby, P.J., et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 4 (1997), 395–409.
59. Garcia-Tejedor, A., Maiques-Montesinos, V., Diago-Almela, V.J., et al. Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers. Eur J Obstet Gynecol Reprod Biol 194 (2015), 173–177.
60. European Pediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. Br J Obstet Gynaecol 108 (2001), 371–377.
61. American Academy of Pediatrics. Recommendations for care of children in special circumstances: hepatitis C. In: Committee on Infectious Diseases; American Academy of Pediatrics; Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 report of the Committee on Infectious Diseases. Elk Grove Village (IL): American Academy of Pediatrics; 2015:197.